{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=IBD&page=50", "query": { "condition": "IBD", "page": 50 }, "page_size": 10 }, "pagination": { "page": 50, "page_size": 10, "total_count": 1553, "total_pages": 156, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=IBD&page=51&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=IBD&page=49&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-26T06:14:58.029Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00742781", "title": "Vitamin D Supplementation in Crohn's Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Inflammatory Bowel Disease" ], "interventions": [ { "name": "Vitamin D", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DIETARY_SUPPLEMENT" ], "sponsor": "Penn State University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 21, "start_date": "2009-05", "completion_date": "2011-12", "has_results": true, "last_update_posted_date": "2013-07-26", "last_synced_at": "2026-10-26T06:14:58.029Z", "location_count": 2, "location_summary": "Hershey, Pennsylvania • University Park, Pennsylvania", "locations": [ { "city": "Hershey", "state": "Pennsylvania" }, { "city": "University Park", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT00742781" }, { "nct_id": "NCT00622557", "title": "General Surgical Outcomes Quality Improvement Database (UH-SOCRATES)", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Colon Cancer", "Diverticulitis", "Colorectal Polyps", "Crohn's Disease", "Ulcerative Colitis", "Rectal Cancer" ], "interventions": [], "intervention_types": [], "sponsor": "University Hospitals Cleveland Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "14 Years", "maximum_age": "95 Years", "sex": "ALL", "summary": "14 Years to 95 Years" }, "enrollment_count": 200000, "start_date": "2007-05-01", "completion_date": "2017-01-06", "has_results": false, "last_update_posted_date": "2022-05-12", "last_synced_at": "2026-10-26T06:14:58.029Z", "location_count": 1, "location_summary": "Cleveland, Ohio", "locations": [ { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT00622557" }, { "nct_id": "NCT05509777", "title": "A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Crohn's Disease" ], "interventions": [ { "name": "Mirikizumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "2 Years to 17 Years" }, "enrollment_count": 90, "start_date": "2024-03-13", "completion_date": "2028-04", "has_results": false, "last_update_posted_date": "2026-10-07", "last_synced_at": "2026-10-26T06:14:58.029Z", "location_count": 15, "location_summary": "Los Angeles, California • Hartford, Connecticut • Atlanta, Georgia + 9 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Hartford", "state": "Connecticut" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Indianapolis", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT05509777" }, { "nct_id": "NCT06538649", "title": "Effect of Statins on Crohn's Disease", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Crohn's Ileocolitis", "Crohn Disease" ], "interventions": [ { "name": "Rosuvastatin", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Stanford University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 20, "start_date": "2024-12-12", "completion_date": "2028-10-31", "has_results": false, "last_update_posted_date": "2026-02-27", "last_synced_at": "2026-10-26T06:14:58.029Z", "location_count": 1, "location_summary": "Stanford, California", "locations": [ { "city": "Stanford", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06538649" }, { "nct_id": "NCT01570348", "title": "Crohn's Allogeneic Transplant Study", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Crohn Disease" ], "interventions": [ { "name": "Allogeneic Bone Marrow Transplantation", "type": "PROCEDURE" }, { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "Fludarabine Phosphate", "type": "DRUG" }, { "name": "Laboratory Biomarker Analysis", "type": "OTHER" }, { "name": "Mycophenolate Mofetil", "type": "DRUG" }, { "name": "Mycophenolic Acid", "type": "DRUG" }, { "name": "Quality-of-Life Assessment", "type": "OTHER" }, { "name": "Tacrolimus", "type": "DRUG" }, { "name": "Total-Body Irradiation", "type": "RADIATION" } ], "intervention_types": [ "PROCEDURE", "DRUG", "OTHER", "RADIATION" ], "sponsor": "Fred Hutchinson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 2, "start_date": "2012-07-17", "completion_date": "2019-10-30", "has_results": true, "last_update_posted_date": "2020-02-17", "last_synced_at": "2026-10-26T06:14:58.029Z", "location_count": 1, "location_summary": "Seattle, Washington", "locations": [ { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT01570348" }, { "nct_id": "NCT00440817", "title": "An Observational Study of Lymphoma in Patients With Rheumatoid Arthritis or Crohn's Disease.", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Lymphoma" ], "interventions": [ { "name": "No intervention", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Centocor Ortho Biotech Services, L.L.C.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 120, "start_date": "2006-02", "completion_date": "2006-08", "has_results": false, "last_update_posted_date": "2014-04-10", "last_synced_at": "2026-10-26T06:14:58.029Z", "location_count": 3, "location_summary": "Highland Park, Illinois • Wichita, Kansas • Albany, New York", "locations": [ { "city": "Highland Park", "state": "Illinois" }, { "city": "Wichita", "state": "Kansas" }, { "city": "Albany", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00440817" }, { "nct_id": "NCT02566889", "title": "An Efficacy and Safety Study of Infliximab Dose Escalation in Pediatric Participants With Inflammatory Bowel Disease", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Inflammatory Bowel Diseases" ], "interventions": [ { "name": "Infliximab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Janssen Scientific Affairs, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": "16 Years", "sex": "ALL", "summary": "6 Years to 16 Years" }, "enrollment_count": 53, "start_date": "2016-04", "completion_date": "2019-07", "has_results": true, "last_update_posted_date": "2025-02-04", "last_synced_at": "2026-10-26T06:14:58.029Z", "location_count": 29, "location_summary": "Phoenix, Arizona • Los Angeles, California • San Francisco, California + 26 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Hartford", "state": "Connecticut" }, { "city": "Wilmington", "state": "Delaware" } ], "official_url": "https://clinicaltrials.gov/study/NCT02566889" }, { "nct_id": "NCT05291689", "title": "A Phase 2a Open-Label Study to Evaluate the Efficacy and Safety of MORF-057 in Adults With UC", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Inflammatory Bowel Diseases", "Colitis, Ulcerative" ], "interventions": [ { "name": "MORF-057", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 39, "start_date": "2022-04-13", "completion_date": "2025-02-19", "has_results": true, "last_update_posted_date": "2026-03-11", "last_synced_at": "2026-10-26T06:14:58.029Z", "location_count": 5, "location_summary": "Tampa, Florida • Lafayette, Louisiana • Freehold, New Jersey + 2 more", "locations": [ { "city": "Tampa", "state": "Florida" }, { "city": "Lafayette", "state": "Louisiana" }, { "city": "Freehold", "state": "New Jersey" }, { "city": "Brooklyn", "state": "New York" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT05291689" }, { "nct_id": "NCT01004185", "title": "Assessing the Safety/Efficacy of Asacol® Given Every 12 Hours to Children and Adolescents for the Maintenance of Remission of Ulcerative Colitis", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Ulcerative Colitis" ], "interventions": [ { "name": "Asacol 400 mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Warner Chilcott", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "5 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "5 Years to 17 Years" }, "enrollment_count": 39, "start_date": "2009-10", "completion_date": "2011-03", "has_results": true, "last_update_posted_date": "2012-05-25", "last_synced_at": "2026-10-26T06:14:58.029Z", "location_count": 25, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Loma Linda, California + 21 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Loma Linda", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01004185" }, { "nct_id": "NCT03941184", "title": "Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "SCAD", "Addison Disease", "Ankylosing Spondylitis", "Antiphospholipid Antibody Syndrome", "Celiac Disease", "Crohn Disease", "Dermatomyositis", "Polymyositis", "Guillain-Barre Syndrome", "Hepatitis, Autoimmune", "Graves Disease", "Hashimoto Thyroiditis", "Multiple Sclerosis", "Myasthenia Gravis", "Pernicious Anemia", "Polymyalgia Rheumatica", "Primary Biliary Cirrhosis", "Psoriasis", "Rheumatoid Arthritis", "Systemic Sclerosis", "Sjögren Syndrome", "Systemic Lupus Erythematosus", "Takayasu Arteritis", "Type 1 Diabetes Mellitus", "Ulcerative Colitis", "Uveitis", "Vasculitis", "Vitiligo", "Raynaud" ], "interventions": [], "intervention_types": [], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": null, "eligibility": { "minimum_age": "18 Years", "maximum_age": "110 Years", "sex": "ALL", "summary": "18 Years to 110 Years" }, "enrollment_count": 114, "start_date": "1995-01-01", "completion_date": "2020-11-10", "has_results": false, "last_update_posted_date": "2020-11-23", "last_synced_at": "2026-10-26T06:14:58.029Z", "location_count": 1, "location_summary": "Rochester, Minnesota", "locations": [ { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT03941184" } ] }